Coalition Warns Administration’s Drug Pricing Index Would Limit Access

Drug Industry Daily
A coalition of more than 200 healthcare advocacy and biopharma groups warned congressional leaders on Monday of unintended consequences of the Trump administration’s proposal to tie Medicare Part B drug prices to those of foreign countries.

To View This Article:


Subscribe To Drug Industry Daily